Hyaluronate sodium
Hyaluronate sodium is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Novartis Pharmaceuticals
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| vaginne intimate hygiene wash | unapproved drug other | 2023-05-26 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
473 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 11 | 18 | 19 | 20 | 24 | 80 |
| Dry eye syndromes | D015352 | H04.12 | — | 3 | 7 | 9 | 16 | 35 | |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 7 | 12 | 7 | 4 | 10 | 33 |
| Cataract | D002386 | EFO_0001059 | H26.9 | 1 | — | 2 | 4 | 7 | 14 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | 2 | 1 | 3 | 6 |
| Gingival recession | D005889 | K06.0 | 1 | 3 | 1 | 1 | 2 | 6 | |
| Chronic periodontitis | D055113 | EFO_0006343 | K05.3 | — | 1 | — | 1 | 3 | 5 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | 2 | 1 | 1 | 1 | 1 | 5 |
| Shoulder pain | D020069 | HP_0030834 | M25.51 | — | — | — | 1 | 4 | 5 |
| Glaucoma | D005901 | EFO_0000516 | H40 | 1 | 1 | — | 1 | 3 | 5 |
Show 40 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Shoulder impingement syndrome | D019534 | EFO_1001178 | M75.4 | — | 1 | 1 | — | 2 | 3 |
| Periodontal pocket | D010514 | EFO_1001393 | — | — | 2 | — | 1 | 3 | |
| Aphthous stomatitis | D013281 | EFO_0003938 | K12.0 | — | — | 1 | — | 1 | 2 |
| Phacoemulsification | D018918 | 1 | — | 1 | — | — | 2 | ||
| Bone resorption | D001862 | — | — | 1 | — | 1 | 2 | ||
| Periodontal diseases | D010510 | K05.6 | — | — | 1 | — | 1 | 2 | |
| Trigger finger disorder | D052582 | M65.3 | — | 1 | 1 | — | — | 1 | |
| Oral submucous fibrosis | D009914 | K13.5 | — | — | 1 | — | — | 1 | |
| Surgical wound | D000072836 | — | — | 1 | — | — | 1 | ||
| Gingivitis | D005891 | K05.10 | — | — | 1 | — | — | 1 |
Show 7 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alveolar bone loss | D016301 | 1 | 1 | — | — | 2 | 3 | ||
| Hearing loss | D034381 | EFO_0004238 | H91.9 | 1 | 2 | — | — | — | 2 |
| Anterior cruciate ligament injuries | D000070598 | 2 | 1 | — | — | — | 2 | ||
| Intervertebral disc degeneration | D055959 | HP_0008419 | 1 | 1 | — | — | — | 2 | |
| Ankle injuries | D016512 | S93.4 | — | 1 | — | — | 1 | 2 | |
| Sudden hearing loss | D003639 | 1 | 1 | — | — | — | 1 | ||
| Noise-induced hearing loss | D006317 | EFO_1001254 | 1 | 1 | — | — | — | 1 | |
| Meniere disease | D008575 | EFO_0006862 | H81.0 | 1 | 1 | — | — | — | 1 |
| Dehydration | D003681 | E86.0 | — | 1 | — | — | — | 1 | |
| Male breast neoplasms | D018567 | — | 1 | — | — | — | 1 |
Show 11 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carpal tunnel syndrome | D002349 | EFO_0004143 | G56.0 | 2 | — | — | — | 2 | 4 |
| Rotator cuff injuries | D000070636 | M75.1 | 1 | — | — | — | 2 | 3 | |
| Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | 1 | — | — | — | 1 | 2 |
| Presbyopia | D011305 | H52.4 | 2 | — | — | — | — | 2 | |
| Intra-articular injections | D007270 | 1 | — | — | — | — | 1 | ||
| Acrodynia | D000170 | EFO_1001756 | 1 | — | — | — | — | 1 | |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | 1 | — | — | — | — | 1 |
| Tissue adhesions | D000267 | 1 | — | — | — | — | 1 | ||
| Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Tennis elbow | D013716 | EFO_1001896 | M77.1 | — | — | — | — | 4 | 4 |
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | — | — | 3 | 3 |
| Interstitial cystitis | D018856 | EFO_1000869 | N30.1 | — | — | — | — | 3 | 3 |
| Atrophy | D001284 | — | — | — | — | 2 | 2 | ||
| Meniscectomy | D000074403 | — | — | — | — | 2 | 2 | ||
| Bursitis | D002062 | EFO_1000941 | M71.9 | — | — | — | — | 2 | 2 |
| Macular edema | D008269 | — | — | — | — | 2 | 2 | ||
| Vaginal diseases | D014623 | — | — | — | — | 2 | 2 | ||
| Patellofemoral pain syndrome | D046788 | EFO_1001092 | — | — | — | — | 2 | 2 | |
| Tendinopathy | D052256 | EFO_1001434 | M77.9 | — | — | — | — | 2 | 2 |
Show 56 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | HYALURONATE SODIUM |
| INN | — |
| Description | Hyaluronate sodium is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 9004-61-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4594244 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 201 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
21,466 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more